Ophthalmic Femtosecond Lasers (OFL) Market Analysis-2026
Ophthalmic Femtosecond Lasers Market Report Analyses competitive environment such as key players, future trends, growths, challenges and acquisitions in the market.
Flap creation in laser in situ keratomileusis (LASIK) is the most common use of this type of laser. It can also be used for other corneal refractive procedures, cataract surgery, and lamellar and full thickness corneal transplantation.
According to Centre for Disease Control and Prevention (CDC), cataract is the prominent blinding condition in the 116 countries enclosed by the Blindness Data Bank in the World Health Organization (WHO) Program for the Prevention of Blindness, nearly 42 million people were affected by severe loss of vision.
Browse Research Report: https://www.coherentmarketinsights.com/
Potential target population in the U.S.
According to Centre for Disease Control and Prevention in 2015, approximately 20.5 million people in the U.S. suffered from cataract, mainly those aged 40 years and older. One of the foremost drivers for ophthalmic femtosecond lasers market is an increasing incidence rate of cataract and rising geriatric population.
Due to large base of the population, China is expected to emerge as the most attractive domestic market for ophthalmic lasers in Asia Pacific. The Middle East and Africa and Latin America are also projected to witness a considerable rise in their respective markets for ophthalmic lasers in the near future, due to the thriving medical tourism and the low cost of laser eye surgeries in these regions.
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy of this report: https://www.coherentmarketinsights.com/
In September 2019, SCHWIND eye-tech-solutions GmbH & Co. KG, introduced Schwind ATOS, a new femtosecond laser with smartsight procedure.
In 2018, LENSAR Inc., acquired laser business unit from Precision Eye Services, Inc. (PES).
In 2014, Abbott Laboratories acquired OptiMedica Corporation, an ophthalmic device company, to expand its femtosecond laser-assisted cataract surgery portfolio.
Buy-Now this research report: https://www.coherentmarketinsights.com/